* Q3'21 sales of KRW 25.5 billion increased 15% from the same period last year * Q3'21 operating ...
* CGBIO, NDR Medical Technology, forge a partnership in a move to introduce puncture robot techno...
SEOUL, South Korea, Aug. 19, 2021 /PRNewswire/ -- Daewoong Pharmaceutical and Hanall Biopharma ofSo...
* Q2'21 sales of KRW 23.4 billion increased 4% from the same period last year * Q2'21 operating ...
- Improvement of symptoms such as cough and dyspnea in mild patients over age 50 was reported to be...
SEOUL, South Korea, June 1, 2021 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Sengho Jeon) announce...
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage ...
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage *...
* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery ...
* Q1'21 sales of KRW 27.8 billion increased 26% compared to Q1'20 * Q1'21 operating profit of KR...